hpv positive oropharyngeal squamous cell carcinoma
Showing 1 - 20 of 20
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma, Oropharynx Cancer Trial in United States (other, radiation, diagnostic
Not yet recruiting
- Head and Neck Cancer
- +4 more
- Experimental Observation
- +3 more
-
Baltimore, Maryland
- +5 more
Oct 16, 2023
Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,
Not yet recruiting
- Head and Neck Cancer
- +20 more
- TSC-204-A0201
- +4 more
-
Scottsdale, Arizona
- +1 more
Aug 3, 2023
Using Human Papillomavirus DNA Testing to Detect HPV-Related
Recruiting
- Oropharyngeal Cancer
- +2 more
- NavDx
-
Basking Ridge, New Jersey
- +6 more
Apr 3, 2023
Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)
Not yet recruiting
- Cervical Cancer
- +20 more
- E7 TCR-T cells
-
New Brunswick, New Jersey
- +1 more
Jan 18, 2023
HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T
Not yet recruiting
- HPV-Associated Cervical Carcinoma
- +16 more
- Conditioning, E7 TCR-T cells, and aldesleukin
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 17, 2023
Will Permit Sites to Proactively Assess TAA, HLA and HPV-16
Terminated
- Head and Neck Cancer
- +7 more
- Tumor Profiling
-
Scottsdale, Arizona
- +2 more
Dec 2, 2022
HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Orange (Intensity-Modulated Radiation Therapy (IMRT))
Recruiting
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- Intensity-Modulated Radiation Therapy (IMRT)
-
Orange, CaliforniaChao Family Comprehensive Cancer Center, University of Californi
Nov 4, 2022
Head Neck Cancer, Oropharynx Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Columbia (Cisplatin injection)
Recruiting
- Cancer of the Head and Neck
- +3 more
- Cisplatin injection
-
Columbia, MissouriUniversity of Missouri
Oct 31, 2022
Squamous Cell Carcinoma of the Oropharynx, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Carmel, Indianapolis (44
Recruiting
- Squamous Cell Carcinoma of the Oropharynx
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- 44 doses of radiation
- 54 doses of radiation
-
Carmel, Indiana
- +1 more
Oct 5, 2022
Head Neck Cancer, Squamous Cell Carcinoma of the Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in New
Completed
- Head and Neck Cancer
- +2 more
- ADXS11-001 (ADXS-HPV)
-
New York, New York
- +1 more
Sep 9, 2022
Human Papilloma Virus, HPV, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Chicago (HB-201, HB-202, Carboplatin)
Recruiting
- Human Papilloma Virus
- +3 more
- HB-201
- +4 more
-
Chicago, IllinoisUniversity of Chicago
Aug 11, 2022
HPV-Associated Oropharyngeal Squamous Cell Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Mediated
Recruiting
- HPV-Associated Oropharyngeal Squamous Cell Carcinoma
- +11 more
- NavDx HPV ctDNA Testing
- +2 more
-
Boston, Massachusetts
- +1 more
Jul 6, 2022
HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in United States (Cisplatin-based Radiation Therapy, Cisplatin
Recruiting
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- Cisplatin-based Radiation Therapy
- Cisplatin Chemotherapy
-
Beverly Hills, California
- +3 more
Jul 6, 2022
HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Boston (Blood test for HPV DNA)
Recruiting
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- Blood test for HPV DNA
-
Boston, MassachusettsBrigham and Women's Hospital
Jun 8, 2022
HPV Positive Oropharyngeal Squamous Cell Carcinoma, HIV-1-infection, HPV Infection Trial in São Paulo, Cuernavaca, San Juan (9
Recruiting
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- +2 more
- 9 valent human papillomavirus vaccine (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
- Saline Placebo
-
São Paulo, Brazil
- +2 more
Mar 25, 2022
Solid Tumor, Microsatellite Stable Colorectal Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Canada, Korea,
Recruiting
- Solid Tumor
- +8 more
- TBio-6517
- Pembrolizumab
-
Phoenix, Arizona
- +10 more
Feb 21, 2022
Carcinoma, Squamous Cell of Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma, Hypopharyngeal Cancer Trial in
Completed
- Carcinoma, Squamous Cell of Head and Neck
- +5 more
- BKM120
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 24, 2022
HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Australia, New Zealand (Cetuximab, RT (70 Gy in 35 fractions),
Active, not recruiting
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- Cetuximab
- +2 more
-
Canberra, Australian Capital Territory, Australia
- +15 more
Feb 7, 2021
Oropharyngeal Squamous Cell Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial (Computed Tomography, Positron
Withdrawn
- Oropharyngeal Squamous Cell Carcinoma
- HPV Positive Oropharyngeal Squamous Cell Carcinoma
- Computed Tomography
- Positron Emission Tomography
- (no location specified)
Aug 5, 2019